Search results
2-in-1 shot for flu and COVID shows promise in advanced trial
LiveScience· 4 days agoAn experimental two-in-one vaccine triggered strong immune responses against both the flu and SARS-CoV-2, the virus behind COVID-19, ...
FDA reverses course, calls for vaccines for fall 2024 to target newer COVID-19 strain
Scripps News via AOL· 15 hours agoThe FDA is reversing course on its COVID vaccine guidance: Rather than having a vaccine that targets...
COVID could damage your vision, new study says. Keep an eye out for these symptoms
Fortune· 4 days agoSARS-CoV-2 does so by breaching the blood-retinal barrier, layers of cells that shield the retina, the part of your eye that senses light ...
Roche Molecular Respiratory Virus Panel Receives FDA Emergency Use Authorization
GenomeWeb News· 5 days agoThe PCR-based test detects SARS-CoV-2, influenza A/B, and respiratory syncytial virus from a nasal swab sample.
FDA modifies strain recommendation for fall COVID vaccine amid variant shifts, uptick in cases
Center for Infectious Disease Research and Policy· 14 hours agoOn June 5, the FDA's vaccine advisory group recommended a switch to the JN.1 variant, though it held...
New Definition Of Long Covid Recommended By Expert Panel
Forbes· 3 days agoIn their report, the group defined LC as, “an infection-associated chronic condition that occurs...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 23 hours agoThe latest efficacy data align with the immunogenicity results, indicating that mRNA-1283 elicits...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 5 days agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
National Academies Issue New Broad Definition of Long COVID
Medscape· 4 days agoAccording to the 2024 NASEM definition of long COVID issued on June 11, 2024, "Long COVID is an...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 21 hours agoCyanVac and its affiliate Blue Lake Biotechnology are developing the single-dose, intranasal vaccine...